Bladder augmentation can be problematic with renal failure and transplantation

被引：0

作者：

Edward J. Alfrey

Oscar Salvatierra

Diana C. Tanney

Robert Mak

John D. Scandling

Donald C. Dafoe

Gregory B. Hammer

Pamela D. Orlandi

Leigh Page

Susan B. Conley

机构：

[1] Department of Surgery,

[2] Stanford University,undefined

[3] Stanford,undefined

[4] California 94305,undefined

[5] USA,undefined

[6] Department of Pediatrics,undefined

[7] Stanford University,undefined

[8] Stanford,undefined

[9] California 94305,undefined

[10] USA,undefined

[11] Department of Medicine,undefined

[12] Stanford University,undefined

[13] Stanford,undefined

[14] California 94305,undefined

[15] USA,undefined

[16] Department of Anesthesia,undefined

[17] Stanford University,undefined

[18] Stanford,undefined

[19] California 94305,undefined

[20] USA,undefined

来源：

Pediatric Nephrology | 1997年 / 11卷

关键词：

Key words: Bladder augmentation; Renal failure; Transplantation; End-stage renal disease; Complications;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Ten consecutive patients with failure of urinary bladder augmentation (UBA) performed either prior to or after reaching end-stage renal disease (ESRD) were studied. Seven patients developed increased hydroureteronephrosis, infectious complications, and advanced to ESRD after UBA. The mean time to development of ESRD in patients who had UBA performed with moderate chronic renal failure (CRF) was 1.8 years. The UBAs in all seven patients were taken down prior to transplantation. Subsequently, five of these UBA-takedown patients have received kidney grafts and all have stable, good renal function. Three patients had their UBA performed after they reached ESRD, in preparation for renal transplantation. All three of these patients experienced recurrent urosepsis following transplantation, resulting in death in one patient and loss of graft in another. The third patient will undergo takedown of the UBA. This study suggests that UBA may possibly not be the best option for patients with moderate CRF and those awaiting transplantation.

引用

页码：672 / 675

页数：3